3P BIOTECH NORWAY AS: årsregnskap 2010 vs 2009
Mixed movements in the accounts
Summary
What changed
Comparing Årsregnskap 2010 with 2009 for 3P BIOTECH NORWAY AS. Equity 15.1k NOK → -20.5k NOK.
On the constructive side: operating result improved. Pressures included: equity eroded.
Also worth watching: thin equity buffer. All figures are taken from the published annual accounts for 3P BIOTECH NORWAY AS.
At a glance
Scorecard
Revenue
21.7k NOK
n/m
—
Operating result
-56.3k NOK
-35.7k NOK
+36.7%
Equity
15.1k NOK
-20.5k NOK
-235.9%
Cash
12.4k NOK
n/m
—
Total assets
130.6k NOK
108.2k NOK
-17.1%
What improved
-
↑
Operating result improved
Operating result -56.3k NOK → -35.7k NOK. Calculated
What deteriorated
-
↓
Equity eroded
Book equity 15.1k NOK → -20.5k NOK (equity ratio 11.6% → -19.0%). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is -19.0% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation